| Variables | UC (n = 39) | CD (n = 22) | IBD (n = 61) | p |
| Gender n (%) | ||||
| Male | 15 (38.5) | 10 (45.5) | 25 (41.0) | 0.59 |
| Female | 24 (61.5) | 12 (54.4) | 36 (59.0) | |
| Age (years) mean ± SD | 46.1 ± 13.8 | 39.9 ± 9.7 | 43.8 ± 12.8 | 0.07 |
| Schooling n (%) | ||||
| <1 years | 00 (0.0) | 01 (4.5) | 01 (1.6) | 0.23 |
| 1 - 8 years | 11 (28.2) | 03 (13.6) | 14 (23.0) | |
| 9 - 11 years | 23 (59.0) | 13 (59.1) | 36 (59.0) | |
| ≥12 years | 05 (12.8) | 05 (22.7) | 10 (16.4) | |
| Income n (%) | * | * | ||
| 1˚ tercil (≤1 MS) | 10 (25.6) | 05 (23.8) | 15 (25.0) | 0.25 |
| 2˚ tercil (1.1 - 3.5 MS) | 20 (51.3) | 07 (33.3) | 27 (45.0) | |
| 3˚ tercil (>3.5 MS) | 09 (23.1) | 09 (42.9) | 18 (30.0) | |
| BMI classification n (%) | ||||
| Underweight | 04 (10.5) | 03 (13.6) | 07 (11.7) | 0.37 |
| Normal | 24 (63.2) | 11 (50,0) | 35 (58.3) | |
| Overweight | 07 (18.4) | 03 (13.6) | 10 (16.7) | |
| Obesity | 03 (7.9) | 05 (22.7) | 08 (13.3) | |
| Disease duration (years) mean ± SD | 7.2 ± 4.8 | 6.7 ± 3.1 | 7.0 ± 4.2 | 0.62 |
| Location of disease n (%) | ||||
| Terminal ileum | - | 05 (22.7) | - | - |
| Colon | - | 09 (40.9) | - | |
| Ileocolon | - | 08 (36.4) | - | |
| Upper GI | 00 (0.0) | - | ||
| Extent of disease n (%) | ||||
| Distal | 20 (51.3) | - | - | - |
| Left-sided | 08 (20.5) | - | - | |
| Extensive | 11 (28.2) | - | - | |
| Disease activity n (%) | ||||
| Activity | 03 (7.7) | 04 (18.2) | 07 (11.5) | 0.24 |
| Remission | 36 (92.3) | 18 (81.8) | 54 (88.5) | |
| Complications of disease n (%) | ||||
| Yes | 02 (5.1) | 06 (27.3) | 08 (13.1) | 0.02 |
| No | 37 (94.9) | 16 (72.7) | 53 (86.9) | |
| Gastrointestinal symptoms n (%) | ||||
| Yes | 18 (46.2) | 15 (68.2) | 33 (54.1) | 0.09 |
| No | 21 (53.8) | 07 (31.8) | 28 (45.9) |